南宫NG·28(中国)相信品牌力量

Shanghai, China – From August 21 to August 25, Shanghai MicroPort Medical (Group) Co., Ltd.("MicroPort®") hosted the 9th Aorta Intervention International Forum in three cities of China including Shanghai, Beijing and Changsha. During the forum, surgeons and distributors from Argentina and Dominican Republic were invited to visit Fuwai Hospital of Chinese Academy of Medical Sciences and the Second Xiangya Hospital of Central South University for academic exchange.

On August 21, MicroPort® hosted the opening ceremony of the 9th Aorta intervention International Forum in its Shanghai headquarters. Dr. Linda Lin, First Vice President of MicroPort® International Business, delivered the opening speech. She briefed the overview of MicroPort®'s history, business segments, and future development plan with emphasis on its globalization strategy and its international business development. Afterwards, the surgeons and distributors from Latin America visited Self-Experience Center to learn about innovative products and technologies of MicroPort®'s various business segments. On the same day, they visited MicroPort Endovascular (Shanghai) Co., Ltd. ("MicroPort® Endovascular") to learn about its aortic product lines, and were shown around the production cleaning room of aortic products. The experts were impressed by the outstanding innovative ability and diversified development strategy of MicroPort® and highly recognized the performance of several MicroPort® Products.

On August 23, the Latin American surgeons and distributors visited the Second Xiangya Hospital of Central South University. The vascular surgery department of the hospital has gained rich clinical experience in aortic endovascular repair and in 2016 alone it completed more than 380 such surgeries with lower mortality rate and complication rate compared to the international average. Professor Chang Shu of the Second Xiangya Hospital of Central South University and his team prepared case studies, seven thoracic endovascular aortic repair surgeries, and one complex open surgery of aneurysms of iliac artery for the surgeons. In one of these surgeries, he adopted fenestration technique and preserved the left common carotid artery and the left subclavian artery. "Chinese surgeons' surgical technique is amazing!" said Walter Chaui, an Argentina vascular surgery physician, after observing Professor Chang Shu using fenestration technique to preserve the left common carotid artery and the left subclavian artery. Professor Chang Shu shared his personal experience with the Latin American experts and they took turns to assist him in the surgeries. Walter Chaui said, it was exciting to be the assistant of Professor Chang Shu and he learnt a lot from such experience. Meanwhile, there were also lectures and Q&A sessions in which Professor Chang Shu actively interacted with the attendees regarding questions about the surgeries.

From August 24 to August 25, the Latin American experts went to Beijing for surgical observation. In Fuwai Hospital of Chinese Academy of Medical Sciences, Professor Chang Shu and his team gave lectures themed on "aortic arch treatment and trend" and "hybrid repair of extensive aortic arch disease." Meanwhile, these experts were divided into groups to observe surgeries including thoracic endovascular aortic repair, prosthetic vessel replacement, and hybrid aortic arch replacement performed by Professor Chang Shu using MicroPort® Endovascular's Hercules®-T Low Profile Thoracic Stent-Graft System and Delivery system, and had discussions with him about the surgical cases and chimney techniques. Professor Chang Shu's sophisticated surgical techniques were highly recognized by experts in attendance.

In the end of the forum, the Latin American surgeons said this academic exchange was rewarding and fruitful and they would apply the medical concept and surgical techniques learnt in this activity to clinical applications to serve more local patients. Dr. Lin said: "MicroPort® has been hosting the aortic intervention international forums for several consecutive years and the academic exchange between Chinese and foreign surgeons has always played an important role in these events, by which MicroPort® aims to build a platform for academic exchange and medical education. With the promotion of the 'Belt and Road' initiative, we hope that more experts from countries involving in the 'Belt and Road' initiative and Latin American countries along the 'Maritime Silk Road' can come to China for academic exchange, and jointly push the development of aorta interventional therapy.'"